Professor John Crown was awarded the DCU President’s Impact Award for research he leads at the National Institute for Cellular Biotechnology (NICB) to improve the treatment options available to women with metastatic HER2-positive breast cancer. Under his leadership, a new drug combination to treat women with this type of breast cancer, that is based on prior preclinical studies from the Cancer Clinical Research Trust (CCRT) research team based in the NICB, has entered clinical development in a recently opened Phase 1 clinical trial named CAROLINE-1. The CAROLINE-1 study received support from CCRT, The Caroline Foundation, BreastPredict and Puma Biotechnology Inc.
Similar Posts
Cluster Nurses Awarded Prestigious Irish Cancer Society Grant
The Nurse Preceptorship Award is a grant offered by the Irish Cancer Society to support Irish…
First-in-world, Caroline-1 clinical trial, will commence this month at St. Vincent’s University Hospital under the leadership of Professor John Crown
As a result of many years of collaborative research by CCRT and The Caroline Foundation funded researchers based…
CCRT Trial Process Mapping and Away Day
Optimising clinical trials is paramount for delivering effective treatments to our patients. The UCD Cancer Trials…